Phosphofructokinase deficiency: Difference between revisions
No edit summary |
No edit summary |
||
Line 14: | Line 14: | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
'''''Synonyms and Keywords:''''' Glycogenosis type 7; Tarui disease; glycogen storage disease type 7; glycogen storage disease type VII | '''''Synonyms and Keywords:''''' Glycogenosis type 7; Tarui disease; glycogen storage disease type 7; glycogen storage disease type VII | ||
Line 26: | Line 28: | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Needs content]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Inborn errors of metabolism]] | [[Category:Inborn errors of metabolism]] |
Revision as of 17:05, 19 September 2012
Phosphofructokinase deficiency | |
ICD-10 | E74.0 |
---|---|
ICD-9 | 271.0 |
OMIM | 232800 |
DiseasesDB | 5314 |
MeSH | D006014 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Synonyms and Keywords: Glycogenosis type 7; Tarui disease; glycogen storage disease type 7; glycogen storage disease type VII
Overview
Phosphofructokinase deficiency[1], is a metabolic disorder with autosomal recessive inheritance, in which deficiency of the M subunit of the phosphofructokinase enzyme impairs the ability of cells such as erythrocytes and rhabdomyocytes to use carbohydrates (such as glucose) for energy. It may affects humans as well as other mammals (especially dogs). In humans it is the least common type of glycogen storage disease.
Symptoms
The disease presents with exercise-induced muscle cramps and weakness (sometimes rhabdomyolysis), as well as with hemolytic anemia causing dark urine a few hours later.
References